Transcriptionally targeted gene therapy to detect and treat cancer

Lily Wu1, Mai Johnson, Makoto Sato

  • 1Department of Urology, Jonsson Comprehensive Cancer Center, and Crump Institute for Molecular Imaging, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. lwu@mednet.ucla.edu

Insights

Cancer gene therapy aims for targeted cell destruction. Combining imaging and therapeutic genes offers proof of expression and potential for simultaneous cancer detection and destruction.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Achieving high specificity and efficacy in cancer treatment remains a significant challenge.
  • Cancer gene therapy offers a targeted approach to induce cancer cell destruction.
  • Cancer-specific promoters are crucial for targeted gene expression, but high expression levels are needed for therapeutic efficacy.

Purpose of the Study:

  • To explore the integration of imaging reporter genes with therapeutic genes in cancer gene therapy.
  • To provide tangible proof of principle for targeted gene expression in cancer cells.
  • To advance cancer detection, diagnosis, and treatment strategies.

Main Methods:

  • Incorporating an imaging reporter gene in tandem with a therapeutic gene.
  • Utilizing cancer-specific promoters for targeted gene expression.
  • Developing a combined gene-based imaging and therapeutic strategy.

Main Results:

  • The combined approach allows for verification of gene expression at the correct location and sufficient levels.
  • Gene-based imaging can enhance cancer detection and diagnosis.
  • This strategy holds promise for simultaneously identifying and destroying disseminated cancer cells.

Conclusions:

  • Integrating imaging reporter genes with therapeutic genes is a viable strategy for cancer gene therapy.
  • This approach validates targeted gene expression and aids in cancer detection.
  • The 'one-two punch' strategy of simultaneous imaging and therapy offers a promising future for cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...